Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
about
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosisBiomarkers for dementia and mild cognitive impairment in Parkinson's disease.CSF proteins and resting-state functional connectivity in Parkinson disease.Cognitive reserve and β-amyloid pathology in Parkinson diseaseCSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease.Neuroimaging biomarkers for Parkinson disease: facts and fantasy.TMEM230 in Parkinson's disease.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease.Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis.Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's disease.
P2860
Q28082380-0479C1F2-73FD-42E4-B670-B9E941430659Q31097119-0C2BB6F8-8609-46A6-8502-9ADA9F52A3F4Q35771985-2D2B8AAB-C274-4222-A68E-83A7B1B55216Q35875396-7EDA6FE8-3A55-47A1-B0DD-27456C7F035CQ36169215-4FBF492D-61F6-4D90-B3FD-571C2AC58299Q36276502-7FF19FFF-3F8F-40E2-B0BF-8870F2B21694Q38264397-DDEA2B8C-3305-4D38-9EAB-33334EE17C4CQ38812225-56CB06CA-6D5B-44A3-AE11-D110AFB32EC2Q39010887-7B295D42-FE75-4314-BEE4-6C49D535173FQ39366291-CE20C2CE-B9EB-409E-BE7F-05BBC4811BE2Q39691980-7C74D105-F9B2-4EF4-B052-57938D95D2B8Q40053985-B504954F-5900-4C82-83DC-DC1464A0B11AQ45915163-0DB0E086-FCB6-4A45-ABE5-85520123D571Q52801531-D8E41E32-BC80-46C3-BE20-466828C663F6
P2860
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
@ast
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
@en
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
@nl
type
label
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
@ast
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
@en
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
@nl
prefLabel
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
@ast
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
@en
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
@nl
P2093
P2860
P1476
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
@en
P2093
Chandana Buddhala
Meghan C Campbell
Paul T Kotzbauer
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2014.07.043
P577
2014-08-04T00:00:00Z